KAIROS PHARMA, LTD. Money Market Funds, at Carrying Value
KAIROS PHARMA, LTD. (KAPA) had Money Market Funds, at Carrying Value of $2.44 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Money Market Funds, at Carrying Value $2.44M.
- 2026-03-31: Money Market Funds, at Carrying Value $3.61M.
- 2025-12-31: Money Market Funds, at Carrying Value $4.33M.
- 2025-09-30: Money Market Funds, at Carrying Value $5.38M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2026-06-30 | $2.44M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.61M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.33M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.38M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.54M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |